Double-blind, placebo controlled cross-over study to assess efficacy of Levetiracetam in paediatric and childhood Tourette syndrome.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Levetiracetam (Primary)
- Indications Gilles de la Tourette's syndrome
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.